Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3
Authors:
- Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
- Andrei Anatolyevich SavchenkoASAndrei Anatolyevich Savchenko
- Mikhail Aleksandrovich CherepninMCMikhail Aleksandrovich Cherepnin
- Eduard Vilyamovich KasparovEKEduard Vilyamovich Kasparov
- Elena Petrovna TikhonovaETElena Petrovna Tikhonova
- Alexander Viktorovich VasyutinAVAlexander Viktorovich Vasyutin
- Julia Leongardovna TonkikhJTJulia Leongardovna Tonkikh
- Anna Alexandrovna AnisimovaAAAnna Alexandrovna Anisimova
- Vasily Dmitrievich BelenyukVasily Dmitrievich Belenyuk
- Alexandr Gennadyevich BorisovABAlexandr Gennadyevich Borisov
Open Access
- 21 February 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 472
Abstract
Background: NK cells phenotype and functional state in different genotypes of chronic viral hepatitis C (CVHC), depending on liver fibrosis severity, have not been sufficiently studied, which limits the possibilities for the development of pathology therapy. Methods: The CVHC diagnosis was based on the EASL recommendations (2018). Clinical examination with liver elastometry was performed in 297 patients with genotype 1 and in 231 patients with genotype 3 CVHC. The blood NK cells phenotype was determined by flow cytometry in 74 individuals with genotype 1 and in 69 individuals with genotype 3 CVHC. Results: The frequency of METAVIR liver fibrosis stages F3–F4 was 32.5% in individuals with genotype 3, and 20.5% in individuals with genotype 1 CVHC (p = 0.003). In patients with both genotype 1 and genotype 3 CVHC, a decrease in the total number of blood NK cells, CD56brightCD16+ NK cells and an increase in the proportion of CD56dimCD16+ NK cells, CD94+ and CD38 + CD73+ NK cells were registered in patients with fibrosis stage F3–F4 by METAVIR in comparison with persons with METAVIR fibrosis stage F0–F1. Conclusions: In patients with both genotype 1 and genotype 3 CVHC, an imbalance in the ratio between cytokine-producing and cytotoxic NK cells and an increase in the content of NK cells that express inhibitory molecules were determined in patients with severe liver fibrosis.Keywords
Funding Information
- Ministry of Education and Science of the Russian Federation
This publication has 42 references indexed in Scilit:
- EASL Recommendations on Treatment of Hepatitis C 2016Journal of Hepatology, 2017
- Human Circulating and Tissue-Resident CD56bright Natural Killer Cell PopulationsFrontiers in Immunology, 2016
- Natural killer cells in hepatitis C: Current progressWorld Journal of Gastroenterology, 2016
- Natural killer cellsHematology/Oncology and Stem Cell Therapy, 2015
- NK Cell Subset Redistribution during the Course of Viral InfectionsFrontiers in Immunology, 2014
- The Role of Natural Killer Cells in Hepatitis C InfectionAntiviral Therapy, 2013
- Association between hepatitis C and hepatocellular carcinomaJournal of Global Infectious Diseases, 2009
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificityInternational Journal of Cancer, 1975
- „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypeEuropean Journal of Immunology, 1975